India Expects U.S.-Indian Ties Under Freer Embryonic Stem Cell Policy
This article was originally published in PharmAsia News
Executive Summary
Indian research organizations expect to reap the benefits of the U.S. change in policy to free up federal funds for research using embryonic stem cells. The Indian organizations expect foreign research firms to seek collaboration with Indian companies to conduct the research because of the country's cheaper research and trial costs. India's policy on embryonic stem cell research is close to the new U.S. policy and the genetic versatility of its huge population also is highly attractive. Stem cell research in general is expected to grow about 15 percent in India by 2010. (Click here for more